Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors
NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) o...
Saved in:
Published in | Mediators of Inflammation Vol. 2013; no. 2013; pp. 263 - 274-124 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Cairo, Egypt
Hindawi Limiteds
01.01.2013
Hindawi Puplishing Corporation Hindawi Publishing Corporation John Wiley & Sons, Inc Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 0962-9351 1466-1861 1466-1861 |
DOI | 10.1155/2013/405295 |
Cover
Loading…
Abstract | NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3−CD56+ cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2. |
---|---|
AbstractList | NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3
−
CD56
+
cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2. NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3(-)CD56(+) cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2. NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by [CD3.sup.-] [CD56.sup.+] cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKRP1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL2/TKD. The diverse effect of IL-2 or IL15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2. NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3−CD56+ cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2. NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3(-)CD56(+) cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3(-)CD56(+) cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2. |
Audience | Academic |
Author | Pirkova, Petra Sedlackova, Lucie Hromadnikova, Ilona |
AuthorAffiliation | Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University in Prague, Ruska 87, 100 00 Prague, Czech Republic |
AuthorAffiliation_xml | – name: Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University in Prague, Ruska 87, 100 00 Prague, Czech Republic |
Author_xml | – sequence: 1 fullname: Hromadnikova, Ilona – sequence: 2 fullname: Pirkova, Petra – sequence: 3 fullname: Sedlackova, Lucie |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23476104$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktv1DAQgCNURB9w4gyyxKWA0vrt-IK02ha6agUVKlwtJ5l0XWXtxclu6Q_if-Js2opWlVAOo7G_-Tx2Zjfb8sFDlr0m-IAQIQ4pJuyQY0G1eJbtEC5lTgpJtrIdrCXNNRNkO9vtuiuMseC8eJFtU8aVJJjvZH9mvmlX4CtAoUEzj366PgY0O8spCnGIRKBJm04cUufRNCxK523vgkfXrp-jk26ZK5wfQXRrqBHh-QIiOodl72pA-xenR-9RYvs5oOPfywhdN5Smw76eoim0LZpUvVvbPsQbZH2depi70m3S71AlTYjdy-x5Y9sOXt3GvezH5-OL6Ul-9u3LbDo5y63kvM8tLbTQlRaKWVIwbnXRlI3khSqEKpkQolGggQGwRODaipoIamWpWKq3nO1ls9FbB3tlltEtbLwxwTqzWQjx0tjYu6oFUwAnSpc0CRqugVrdFFUy2oqxRlKbXJ9G13JVLqCuwPfRtg-kD3e8m5vLsDZMFAVRIgn2bwUx_FpB15uF66r0YtZDWHWGMCKxkIyQhL4b0UubWnO-CclYDbiZMKW0VpQP1METVPpqWLgq_eLGpfUHBW__vcJ973fjkwAyAlUMXRehMZXrN7ORzK41BJthRM0womYc0VTz8VHNnfZp-sNIz52v7bX7D_xmhCEh0Nh7mEvN5XCf83Hfuuh6Z67CKvo0T-Y8WdJbUoUx2xgJHYLCDFOM6eNEJkhxQyhnfwF4Iw3g |
CitedBy_id | crossref_primary_10_1002_JLB_6RI0917_390R crossref_primary_10_1007_s43032_023_01372_z crossref_primary_10_1097_MPH_0000000000000303 crossref_primary_10_18632_oncotarget_18185 crossref_primary_10_3389_fimmu_2021_816499 crossref_primary_10_1111_aji_12374 crossref_primary_10_3389_fimmu_2016_00066 crossref_primary_10_1016_j_biopha_2023_114257 crossref_primary_10_3892_etm_2017_4562 crossref_primary_10_1155_2016_2085871 crossref_primary_10_3390_jcm9061816 crossref_primary_10_1097_CMR_0000000000000289 crossref_primary_10_1371_journal_pone_0151535 crossref_primary_10_1128_JVI_00235_18 crossref_primary_10_1016_j_canlet_2023_216462 crossref_primary_10_3390_ijms20184588 crossref_primary_10_1111_imm_12516 crossref_primary_10_3892_or_2021_8183 crossref_primary_10_1189_jlb_5A0116_053RR crossref_primary_10_1158_2326_6066_CIR_17_0279 crossref_primary_10_1007_s00432_022_04532_x crossref_primary_10_3389_fimmu_2022_767530 |
Cites_doi | 10.4049/jimmunol.169.8.4253 10.1016/0092-8674(89)90606-5 10.4049/jimmunol.172.2.972 10.1084/jem.190.10.1505 10.1385/IR:35:3:263 10.1002/eji.200425418 10.4049/jimmunol.174.4.2152 10.1084/jem.186.7.1129 10.1038/370151a0 10.1038/icb.2008.5 10.1002/art.27677 10.1007/s00262-009-0680-0 10.1111/j.1365-2249.2004.02686.x 10.1074/jbc.270.24.14679 10.1146/annurev.immunol.22.012703.104711 10.1084/jem.20021127 10.4049/jimmunol.182.2.829 10.1158/1078-0432.CCR-03-0683 10.1111/j.1365-3083.2010.02395.x 10.1016/S0301-472X(98)00055-1 10.1006/geno.2000.6163 10.4049/jimmunol.170.9.4572 10.1038/nri2154 10.1002/eji.1830270612 10.1038/370153a0 10.1084/jem.170.2.481 10.1016/j.jim.2004.08.008 10.1155/MI/2006/46957 10.4049/jimmunol.171.4.1768 10.1186/1479-5876-7-50 10.4049/jimmunol.171.12.6611 10.1038/sj.icb.7100031 10.1016/j.jri.2005.12.008 10.1007/s00018-011-0797-0 10.1038/ni1581 10.1073/pnas.92.2.377 10.4049/jimmunol.161.7.3493 10.1093/neuonc/nop009 10.4049/jimmunol.176.4.2397 10.1034/j.1399-0039.2003.00037.x 10.1158/0008-5472.CAN-11-1565 10.4049/jimmunol.176.10.6270 10.1126/science.8079170 10.1016/j.exphem.2010.02.006 10.4049/jimmunol.168.7.3155 10.1007/s12192-007-0008-y 10.4049/jimmunol.153.6.2417 10.1016/S0021-9258(18)50638-4 10.1182/blood-2002-04-1251 10.1016/j.humimm.2010.06.015 10.1038/sj.onc.1202525 10.1016/1074-7613(95)90140-X 10.1182/blood.V98.3.705 10.1016/j.coi.2004.07.010 10.1038/308693a0 10.1007/s002510050276 10.2217/imt.11.102 10.1016/S0022-1759(02)00084-4 10.1016/j.cellimm.2008.08.007 10.1007/s002510050362 10.1016/1074-7613(95)90013-6 10.4049/jimmunol.158.9.4341 10.1016/S1074-7613(02)00427-2 10.1074/jbc.M601786200 10.4049/jimmunol.171.7.3415 10.1038/ni1487 10.4049/jimmunol.171.10.5277 10.1002/eji.200737266 10.1038/ni1524 10.1159/000205907 |
ContentType | Journal Article |
Contributor | Pirkova, Petra Sedlackova, Lucie |
Contributor_xml | – sequence: 1 fullname: Pirkova, Petra – sequence: 2 fullname: Sedlackova, Lucie |
Copyright | Copyright © 2013 Ilona Hromadnikova et al. COPYRIGHT 2013 John Wiley & Sons, Inc. Copyright © 2013 Ilona Hromadnikova et al. 2013 |
Copyright_xml | – notice: Copyright © 2013 Ilona Hromadnikova et al. – notice: COPYRIGHT 2013 John Wiley & Sons, Inc. – notice: Copyright © 2013 Ilona Hromadnikova et al. 2013 |
DBID | 188 ADJCN AHFXO RHU RHW RHX AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1155/2013/405295 |
DatabaseName | Airiti Library الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1466-1861 |
Editor | Fantuzzi, Giamila |
Editor_xml | – sequence: 1 givenname: Giamila surname: Fantuzzi fullname: Fantuzzi, Giamila |
EndPage | 274-124 |
ExternalDocumentID | oai_doaj_org_article_8e4179b2152f49e2a9f8cda5ac33f62a PMC3588175 A377997241 23476104 10_1155_2013_405295 469461 P20160527003_201312_201703020022_201703020022_263_274_124 |
Genre | Journal Article |
GroupedDBID | --- 188 24P 29M 2UF 2WC 36B 4.4 53G 5GY 5VS AAFWJ AAJEY ABDBF ACGFO ACIHN ADBBV ADRAZ AEAQA AENEX AFPKN AHMBA AINHJ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BCNDV CEFSP CNMHZ CS3 DIK DU5 E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPL ESX F5P GROUPED_DOAJ GX1 H13 HYE IAO IGS IHR IL9 INH INR ITC KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RHU RHX RNS RPM SV3 TR2 TUS UZ5 WOQ WOW ~8M 3V. 7X7 88E 8FE 8FH 8FI 8FJ 8G5 ABUWG ADJCN AFKRA AHFXO AZQEC BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF DWQXO FYUFA GNUQQ GUQSH HCIFZ HMCUK IPNFZ LK8 M1P M2O M7P OVD PIMPY PQQKQ PROAC PSQYO RIG TEORI UKHRP RHW 0R~ AAYXX ACCMX ACUHS CITATION OVT PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7X8 5PM |
ID | FETCH-LOGICAL-a644t-a28959c9573a1834a98fbf6487857b3555f7e9e3ee373a0da5d152a6b73644a43 |
IEDL.DBID | M48 |
ISSN | 0962-9351 1466-1861 |
IngestDate | Wed Aug 27 01:30:31 EDT 2025 Thu Aug 21 14:11:23 EDT 2025 Fri Jul 11 04:24:58 EDT 2025 Wed Mar 19 02:06:37 EDT 2025 Sat Mar 08 18:52:42 EST 2025 Mon Jul 21 05:43:43 EDT 2025 Tue Jul 01 03:54:30 EDT 2025 Thu Apr 24 22:58:27 EDT 2025 Sun Jun 02 18:55:34 EDT 2024 Tue Nov 26 16:44:22 EST 2024 Tue Oct 01 22:52:01 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2013 |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a644t-a28959c9573a1834a98fbf6487857b3555f7e9e3ee373a0da5d152a6b73644a43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Academic Editor: Giamila Fantuzzi |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2013/405295 |
PMID | 23476104 |
PQID | 1316056311 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8e4179b2152f49e2a9f8cda5ac33f62a pubmedcentral_primary_oai_pubmedcentral_nih_gov_3588175 proquest_miscellaneous_1316056311 gale_infotracmisc_A377997241 gale_infotracacademiconefile_A377997241 pubmed_primary_23476104 crossref_citationtrail_10_1155_2013_405295 crossref_primary_10_1155_2013_405295 hindawi_primary_10_1155_2013_405295 emarefa_primary_469461 airiti_journals_P20160527003_201312_201703020022_201703020022_263_274_124 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-01-01 |
PublicationDateYYYYMMDD | 2013-01-01 |
PublicationDate_xml | – month: 01 year: 2013 text: 2013-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cairo, Egypt |
PublicationPlace_xml | – name: Cairo, Egypt – name: United States |
PublicationTitle | Mediators of Inflammation |
PublicationTitleAlternate | Mediators Inflamm |
PublicationYear | 2013 |
Publisher | Hindawi Limiteds Hindawi Puplishing Corporation Hindawi Publishing Corporation John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: Hindawi Limiteds – name: Hindawi Puplishing Corporation – name: Hindawi Publishing Corporation – name: John Wiley & Sons, Inc – name: Wiley |
References | (10) 2011; 3 (17) 1994; 370 (11) 2008; 13 (14) 1998; 161 (36) 2003; 171 (33) 2002; 169 (5) 2006; 176 (2) 1997; 158 (63) 1998; 12 (4) 2004; 172 (70) 2006; 281 (37) 2010; 71 (55) 2010; 12 (51) 2007; 8 (19) 1989; 170 (25) 1989; 59 (34) 2003; 197 (49) 1995; 92 (29) 2007; 85 (16) 1995; 2 (58) 1998; 47 (8) 1987; 78 (71) 2011; 71 (27) 1979; 254 (45) 1994; 153 (18) 1995; 2 (59) 2005; 174 (48) 2004; 22 (20) 2003; 61 (35) 2003; 171 (65) 2002; 17 (74) 2009; 254 (41) 1997; 186 (12) 2006; 2006 (60) 2004; 172 (62) 1997; 27 (53) 2003; 101 (64) 2009; 182 (46) 2011; 68 (50) 2007; 8 (38) 2009; 58 (28) 1995; 270 (40) 2005; 139 (66) 2002; 264 (52) 2002; 168 (15) 1994; 370 (69) 2006; 4 (72) 2010; 62 (6) 2004; 10 (47) 2007; 7 (57) 2003; 171 (21) 2003; 170 (44) 2000; 65 (24) 1994; 265 (26) 1984; 308 (42) 1999; 190 (73) 2004; 294 (56) 2012; 8 (67) 2006; 70 (30) 2008; 86 (1) 1999; 18 (39) 2004; 34 (54) 2010; 38 (68) 2006; 176 (7) 2009; 23 (13) 2006; 35 (23) 2010; 71 (31) 2004; 16 (22) 2007; 37 (3) 1999; 27 (9) 2008; 9 (61) 2001; 98 (43) 1997; 46 (32) 2003; 171 44 47 49 50 51 53 10 54 11 55 12 13 58 15 17 1 3 6 7 9 61 62 20 65 22 66 23 67 25 28 29 70 71 73 30 74 31 34 37 39 40 41 42 43 |
References_xml | – volume: 59 start-page: 827 issue: 5 year: 1989 end-page: 836 ident: 25 article-title: Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 – volume: 171 start-page: 3415 issue: 7 year: 2003 end-page: 3425 ident: 35 article-title: KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN- production – volume: 174 start-page: 2152 issue: 4 year: 2005 end-page: 2159 ident: 59 article-title: GATA-3 is an important transcription factor for regulating human NKG2A gene expression – volume: 139 start-page: 287 issue: 2 year: 2005 end-page: 296 ident: 40 article-title: Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30) – volume: 170 start-page: 4572 issue: 9 year: 2003 end-page: 4577 ident: 21 article-title: TGF- 1 supresses myeloid Fc receptor function by regulating the expression and function of the common -subunit – volume: 265 start-page: 1573 issue: 5178 year: 1994 end-page: 1577 ident: 24 article-title: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages – volume: 2 start-page: 321 issue: 4 year: 1995 end-page: 329 ident: 16 article-title: Identification and purification of human stat proteins activated in response to interleukin-2 – volume: 8 start-page: 66 issue: 1 year: 2012 end-page: 78 ident: 56 article-title: DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8 (+) T and NK cells – volume: 18 start-page: 3648 issue: 24 year: 1999 end-page: 3651 ident: 1 article-title: Oncogenic potential of Hsp72 – volume: 13 start-page: 221 issue: 2 year: 2008 end-page: 230 ident: 11 article-title: Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells – volume: 22 start-page: 405 year: 2004 end-page: 429 ident: 48 article-title: The dynamic life of natural killer cells – volume: 172 start-page: 2152 issue: 4 year: 2004 end-page: 2159 ident: 60 article-title: IL-21 induces the functional maturation of murine NK cells – volume: 171 start-page: 5277 issue: 10 year: 2003 end-page: 5286 ident: 57 article-title: Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15 – volume: 98 start-page: 705 issue: 3 year: 2001 end-page: 713 ident: 61 article-title: Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2 – volume: 169 start-page: 4253 issue: 8 year: 2002 end-page: 4261 ident: 33 article-title: Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells – volume: 171 start-page: 1768 issue: 4 year: 2003 end-page: 1774 ident: 36 article-title: KIR2DL4 (CD158d) genotype influences expression and function in NK cells – volume: 70 start-page: 33 issue: 1-2 year: 2006 end-page: 42 ident: 67 article-title: Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells – volume: 254 start-page: 149 issue: 2 year: 2009 end-page: 154 ident: 74 article-title: Relationship between CD107a expression and cytotoxic activity – volume: 186 start-page: 1129 issue: 7 year: 1997 end-page: 1136 ident: 41 article-title: p46, a novel natural killer cell-specific surface molecule that mediates cell activation – volume: 182 start-page: 829 issue: 2 year: 2009 end-page: 836 ident: 64 article-title: IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function – volume: 17 start-page: 487 issue: 4 year: 2002 end-page: 499 ident: 65 article-title: TCR specificity dictates CD94/NKG2A expression by human CTL – volume: 281 start-page: 28731 issue: 39 year: 2006 end-page: 28736 ident: 70 article-title: Identification and characterization of the CD226 gene promoter – volume: 65 start-page: 129 issue: 2 year: 2000 end-page: 136 ident: 44 article-title: A sequence-ready physical map of the region containing human natural killer gene complex on chromosome 12p12.3-p13.2 – volume: 9 start-page: 495 issue: 5 year: 2008 end-page: 502 ident: 9 article-title: Up on the tightrope: natural killer cell activation and inhibition – volume: 197 start-page: 245 issue: 2 year: 2003 end-page: 255 ident: 34 article-title: DNA methylation maintains allele-specific KIR gene expression in human natural killer cells – volume: 171 start-page: 6611 issue: 12 year: 2003 end-page: 6620 ident: 32 article-title: Transcriptional regulation of ILT family receptors – volume: 47 start-page: 305 issue: 4 year: 1998 end-page: 309 ident: 58 article-title: Structure of the human CD94 C-type lectin gene – volume: 34 start-page: 3028 issue: 11 year: 2004 end-page: 3038 ident: 39 article-title: The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity – volume: 264 start-page: 109 issue: 1-2 year: 2002 end-page: 119 ident: 66 article-title: Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones – volume: 294 start-page: 15 issue: 1-2 year: 2004 end-page: 22 ident: 73 article-title: CD107a as a functional marker for the identification of natural killer cell activity – volume: 38 start-page: 351 issue: 5 year: 2010 end-page: 362 ident: 54 article-title: Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression – volume: 153 start-page: 2417 issue: 6 year: 1994 end-page: 2428 ident: 45 article-title: Human NKR-P1A: a disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes – volume: 58 start-page: 1691 issue: 10 year: 2009 end-page: 1700 ident: 38 article-title: Anti-cancer activity and mechanistic features of a NK cell activating molecule – volume: 2 start-page: 689 issue: 6 year: 1995 end-page: 697 ident: 18 article-title: Components of a Stat recognition code: evidence for two layers of molecular selectivity – volume: 308 start-page: 693 issue: 5961 year: 1984 end-page: 698 ident: 26 article-title: The role of protein kinase C in cell surface signal transduction and tumour promotion – volume: 168 start-page: 3155 issue: 7 year: 2002 end-page: 3164 ident: 52 article-title: Syk regulation of phosphoinositide 3-kinase-dependent NK cell function – volume: 370 start-page: 153 issue: 6485 year: 1994 end-page: 157 ident: 17 article-title: Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells – volume: 71 start-page: 942 issue: 10 year: 2010 end-page: 949 ident: 23 article-title: LILRB1 polymorphism and surface phenotypes of natural killer cells – volume: 16 start-page: 626 issue: 5 year: 2004 end-page: 633 ident: 31 article-title: Killer immunoglobulin-like receptors – volume: 46 start-page: 307 issue: 4 year: 1997 end-page: 311 ident: 43 article-title: The human natural killer gene complex is located on chromosome 12p12-p13 – volume: 172 start-page: 972 issue: 2 year: 2004 end-page: 980 ident: 4 article-title: The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells – volume: 3 start-page: 1143 issue: 10 year: 2011 end-page: 1166 ident: 10 article-title: NK cells: immune cross-talk and therapeutic implications – volume: 4 start-page: 573 issue: 6 year: 2006 end-page: 581 ident: 69 article-title: DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes – volume: 12 start-page: 1165 issue: 5 year: 1998 end-page: 1170 ident: 63 article-title: Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-X and PMA/ionomycin – volume: 27 start-page: 470 issue: 3 year: 1999 end-page: 478 ident: 3 article-title: Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells – volume: 170 start-page: 481 issue: 2 year: 1989 end-page: 497 ident: 19 article-title: Alternative membrane forms of Fc RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions – volume: 35 start-page: 263 issue: 3 year: 2006 end-page: 277 ident: 13 article-title: The CD94/NKG2 family of receptors – volume: 61 start-page: 189 issue: 3 year: 2003 end-page: 202 ident: 20 article-title: Fc R polymorphisms: implications for function, disease susceptibility and immunotherapy – volume: 176 start-page: 6270 issue: 10 year: 2006 end-page: 6276 ident: 5 article-title: Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells – volume: 270 start-page: 14679 issue: 24 year: 1995 end-page: 14684 ident: 28 article-title: Low affinity binding of phorbol esters to protein kinase C and its recombinant cysteine-rich region in the absence of phospholipids – volume: 78 start-page: 75 issue: 1 year: 1987 end-page: 76 ident: 8 article-title: Therapy of cancer using the adoptive transfer of activated killer cells and interleukin-2 – volume: 23 issue: 7, article 50 year: 2009 ident: 7 article-title: Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy: a case report – volume: 68 start-page: 3519 issue: 21 year: 2011 end-page: 3529 ident: 46 article-title: Regulation of immune cell function and differentiation by the NKG2D receptor – volume: 8 start-page: 1345 issue: 12 year: 2007 end-page: 1352 ident: 51 article-title: NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway – volume: 85 start-page: 220 issue: 3 year: 2007 end-page: 228 ident: 29 article-title: Activation-induced upregulation of inhibitory killer Ig-like receptors is regulated by protein kinase C – volume: 86 start-page: 372 issue: 4 year: 2008 end-page: 380 ident: 30 article-title: Amino-acid sequence motifs for PKC-mediated membrane trafficking of the inhibitory killer Ig-like receptor – volume: 71 start-page: 6410 issue: 20 year: 2011 end-page: 6418 ident: 71 article-title: IRF-1 expression is essential for natural killer cells to suppress metastasis – volume: 158 start-page: 4341 issue: 9 year: 1997 end-page: 4350 ident: 2 article-title: Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells – volume: 37 start-page: 2912 issue: 10 year: 2007 end-page: 2922 ident: 22 article-title: Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells – volume: 92 start-page: 377 issue: 2 year: 1995 end-page: 381 ident: 49 article-title: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor chain – volume: 8 start-page: 856 issue: 8 year: 2007 end-page: 863 ident: 50 article-title: Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1 – volume: 12 start-page: 7 issue: 1 year: 2010 end-page: 13 ident: 55 article-title: TGF- downregulates the activating receptor NKG2D on NK cells and CD8 T cells in glioma patients – volume: 10 start-page: 3699 issue: 11 year: 2004 end-page: 3707 ident: 6 article-title: Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial – volume: 254 start-page: 3692 issue: 10 year: 1979 end-page: 3695 ident: 27 article-title: Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids – volume: 71 start-page: 413 issue: 6 year: 2010 end-page: 419 ident: 37 article-title: Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression – volume: 62 start-page: 3404 issue: 11 year: 2010 end-page: 3414 ident: 72 article-title: A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus – volume: 2006 year: 2006 end-page: 6 ident: 12 article-title: Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells – volume: 161 start-page: 3493 issue: 7 year: 1998 end-page: 3500 ident: 14 article-title: Differential transcriptional regulation of and a novel gene, , by IL-2, IL-15, and IL-12 in NK and T cells – volume: 190 start-page: 1505 issue: 10 year: 1999 end-page: 1516 ident: 42 article-title: Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells – volume: 370 start-page: 151 issue: 6485 year: 1994 end-page: 153 ident: 15 article-title: Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2 – volume: 7 start-page: 703 issue: 9 year: 2007 end-page: 714 ident: 47 article-title: Developmental pathways that generate natural-killer-cell diversity in mice and humans – volume: 27 start-page: 1374 issue: 6 year: 1997 end-page: 1380 ident: 62 article-title: Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor – volume: 101 start-page: 236 issue: 1 year: 2003 end-page: 244 ident: 53 article-title: Regulation of Akt-dependent cell survival by Syk and Rac – volume: 176 start-page: 2397 issue: 4 year: 2006 end-page: 2406 ident: 68 article-title: CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase – volume: 169 start-page: 4253 issue: 8 year: 2002 ident: 33 publication-title: Journal of Immunology doi: 10.4049/jimmunol.169.8.4253 – ident: 25 doi: 10.1016/0092-8674(89)90606-5 – volume: 172 start-page: 972 issue: 2 year: 2004 ident: 4 publication-title: Journal of Immunology doi: 10.4049/jimmunol.172.2.972 – ident: 42 doi: 10.1084/jem.190.10.1505 – ident: 13 doi: 10.1385/IR:35:3:263 – ident: 39 doi: 10.1002/eji.200425418 – volume: 174 start-page: 2152 issue: 4 year: 2005 ident: 59 publication-title: Journal of Immunology doi: 10.4049/jimmunol.174.4.2152 – volume: 8 start-page: 66 issue: 1 year: 2012 ident: 56 publication-title: Epigenetics – ident: 41 doi: 10.1084/jem.186.7.1129 – ident: 15 doi: 10.1038/370151a0 – ident: 30 doi: 10.1038/icb.2008.5 – volume: 62 start-page: 3404 issue: 11 year: 2010 ident: 72 publication-title: Arthritis & Rheumatism doi: 10.1002/art.27677 – volume: 58 start-page: 1691 issue: 10 year: 2009 ident: 38 publication-title: Cancer Immunology, Immunotherapy doi: 10.1007/s00262-009-0680-0 – ident: 40 doi: 10.1111/j.1365-2249.2004.02686.x – ident: 28 doi: 10.1074/jbc.270.24.14679 – volume: 22 start-page: 405 year: 2004 ident: 48 publication-title: Annual Review of Immunology doi: 10.1146/annurev.immunol.22.012703.104711 – ident: 34 doi: 10.1084/jem.20021127 – volume: 182 start-page: 829 issue: 2 year: 2009 ident: 64 publication-title: Journal of Immunology doi: 10.4049/jimmunol.182.2.829 – ident: 6 doi: 10.1158/1078-0432.CCR-03-0683 – ident: 37 doi: 10.1111/j.1365-3083.2010.02395.x – ident: 3 doi: 10.1016/S0301-472X(98)00055-1 – ident: 44 doi: 10.1006/geno.2000.6163 – volume: 170 start-page: 4572 issue: 9 year: 2003 ident: 21 publication-title: Journal of Immunology doi: 10.4049/jimmunol.170.9.4572 – ident: 47 doi: 10.1038/nri2154 – ident: 62 doi: 10.1002/eji.1830270612 – ident: 17 doi: 10.1038/370153a0 – volume: 170 start-page: 481 issue: 2 year: 1989 ident: 19 publication-title: Journal of Experimental Medicine doi: 10.1084/jem.170.2.481 – volume: 172 start-page: 2152 issue: 4 year: 2004 ident: 60 publication-title: Journal of Immunology – ident: 73 doi: 10.1016/j.jim.2004.08.008 – ident: 12 doi: 10.1155/MI/2006/46957 – volume: 171 start-page: 1768 issue: 4 year: 2003 ident: 36 publication-title: Journal of Immunology doi: 10.4049/jimmunol.171.4.1768 – ident: 7 doi: 10.1186/1479-5876-7-50 – volume: 171 start-page: 6611 issue: 12 year: 2003 ident: 32 publication-title: Journal of Immunology doi: 10.4049/jimmunol.171.12.6611 – ident: 29 doi: 10.1038/sj.icb.7100031 – ident: 67 doi: 10.1016/j.jri.2005.12.008 – volume: 68 start-page: 3519 issue: 21 year: 2011 ident: 46 publication-title: Cellular and Molecular Life Sciences doi: 10.1007/s00018-011-0797-0 – volume: 12 start-page: 1165 issue: 5 year: 1998 ident: 63 publication-title: International Journal of Oncology – ident: 9 doi: 10.1038/ni1581 – ident: 49 doi: 10.1073/pnas.92.2.377 – volume: 161 start-page: 3493 issue: 7 year: 1998 ident: 14 publication-title: Journal of Immunology doi: 10.4049/jimmunol.161.7.3493 – ident: 55 doi: 10.1093/neuonc/nop009 – volume: 176 start-page: 2397 issue: 4 year: 2006 ident: 68 publication-title: Journal of Immunology doi: 10.4049/jimmunol.176.4.2397 – ident: 20 doi: 10.1034/j.1399-0039.2003.00037.x – ident: 71 doi: 10.1158/0008-5472.CAN-11-1565 – volume: 176 start-page: 6270 issue: 10 year: 2006 ident: 5 publication-title: Journal of Immunology doi: 10.4049/jimmunol.176.10.6270 – volume: 265 start-page: 1573 issue: 5178 year: 1994 ident: 24 publication-title: Science doi: 10.1126/science.8079170 – ident: 54 doi: 10.1016/j.exphem.2010.02.006 – volume: 168 start-page: 3155 issue: 7 year: 2002 ident: 52 publication-title: Journal of Immunology doi: 10.4049/jimmunol.168.7.3155 – ident: 11 doi: 10.1007/s12192-007-0008-y – volume: 4 start-page: 573 issue: 6 year: 2006 ident: 69 publication-title: Immunity – volume: 153 start-page: 2417 issue: 6 year: 1994 ident: 45 publication-title: Journal of Immunology doi: 10.4049/jimmunol.153.6.2417 – volume: 254 start-page: 3692 issue: 10 year: 1979 ident: 27 publication-title: Journal of Biological Chemistry doi: 10.1016/S0021-9258(18)50638-4 – ident: 53 doi: 10.1182/blood-2002-04-1251 – ident: 23 doi: 10.1016/j.humimm.2010.06.015 – ident: 1 doi: 10.1038/sj.onc.1202525 – volume: 2 start-page: 321 issue: 4 year: 1995 ident: 16 publication-title: Immunity doi: 10.1016/1074-7613(95)90140-X – ident: 61 doi: 10.1182/blood.V98.3.705 – ident: 31 doi: 10.1016/j.coi.2004.07.010 – volume: 308 start-page: 693 issue: 5961 year: 1984 ident: 26 publication-title: Nature doi: 10.1038/308693a0 – ident: 43 doi: 10.1007/s002510050276 – ident: 10 doi: 10.2217/imt.11.102 – ident: 66 doi: 10.1016/S0022-1759(02)00084-4 – ident: 74 doi: 10.1016/j.cellimm.2008.08.007 – ident: 58 doi: 10.1007/s002510050362 – volume: 2 start-page: 689 issue: 6 year: 1995 ident: 18 publication-title: Immunity doi: 10.1016/1074-7613(95)90013-6 – volume: 158 start-page: 4341 issue: 9 year: 1997 ident: 2 publication-title: Journal of Immunology doi: 10.4049/jimmunol.158.9.4341 – ident: 65 doi: 10.1016/S1074-7613(02)00427-2 – ident: 70 doi: 10.1074/jbc.M601786200 – volume: 171 start-page: 3415 issue: 7 year: 2003 ident: 35 publication-title: Journal of Immunology doi: 10.4049/jimmunol.171.7.3415 – ident: 50 doi: 10.1038/ni1487 – volume: 171 start-page: 5277 issue: 10 year: 2003 ident: 57 publication-title: Journal of Immunology doi: 10.4049/jimmunol.171.10.5277 – ident: 22 doi: 10.1002/eji.200737266 – ident: 51 doi: 10.1038/ni1524 – volume: 78 start-page: 75 issue: 1 year: 1987 ident: 8 publication-title: Acta Haematologica doi: 10.1159/000205907 |
SSID | ssj0005448 |
Score | 2.1533093 |
Snippet | NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity.... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref hindawi emarefa airiti |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 263 |
SubjectTerms | Antigens, Differentiation, T-Lymphocyte - metabolism Cells, Cultured Health aspects Heat shock proteins HSP70 Heat-Shock Proteins - chemistry Humans Interleukin-15 - pharmacology Interleukin-2 - pharmacology Interleukins Killer cells Killer Cells, Natural - drug effects Killer Cells, Natural - metabolism Leukocytes, Mononuclear - drug effects Leukocytes, Mononuclear - metabolism Lysosomal Membrane Proteins - metabolism Natural Cytotoxicity Triggering Receptor 1 - metabolism Natural Cytotoxicity Triggering Receptor 2 - metabolism Natural Cytotoxicity Triggering Receptor 3 - metabolism NK Cell Lectin-Like Receptor Subfamily B - metabolism NK Cell Lectin-Like Receptor Subfamily C - metabolism NK Cell Lectin-Like Receptor Subfamily K - metabolism Peptides Peptides - chemistry Peptides - pharmacology Receptors, IgG - metabolism Receptors, KIR2DL2 Receptors, KIR2DL4 - metabolism |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXxKsQKMiISjykqBu_Eh-XPrRLadVDi3qznMTRRlqSKrtt4QfxP5lxvKumquDCKfJm1rFnJuNv4vEMIdsA61XpChfnSstYMKfgnUt1rIWQVlaWOZ9n9uhYTc7E13N5fqPUF8aE9emBe8btZA5rZOVYfrUS2jGrq6worbQF55ViHhrBmrdyplbBHcLXzQJ8zmLNZRJO5sHiCd5-wneE3-CCVcfWmDtosCj53P3-gK6Ftl3b6vsz9JKv67uw6O2Qyhtr1MFj8iiASzruJ_WE3HPNU_LgKGyfPyO_p6uSJLSt6LSh3-tl19Lpt5jRtsNrIul43jYOm3VDwVqA5-yFR_GLLZ0sLuJ0FO-B3l65kiYi_uE6eoKhMaWjH08P9z5RoAVUSfd_hhjbBh92fEh33RzGVvh6am33i9qmhDHM6rz2TQCw0E3bLZ6Ts4P9091JHOo0xBbQ1DK24LRJXWiZcgsWQlidVXmlwBXKZJoDoJFV6rTjznGgGIHwSpCmVXnK4f9W8E2y0cDUXhKqimqkNHjspeVCFCpHOTNmYRW1irE8ItNeYia8agtzwjBJnsQNdG5QuAnDC1oyDEC53VBAlAoDsCYin1dCN0VIiI51OebGO0ZS-t5MryoR2V4TX_R5QO4m-4LasybB5N3-B1BpE1Ta_EulI7IZdG_dj1BaqCQiH1AVDdoeGGlhwxEK4B1m8TJjzB6pUwBlEdkaUILNKAa33wdl_vtk3q0U3WAHGI7XuPZyYYDJwHLFE-jpRa_4644YFylgcmBvOnglBjwZ3mnqmU9szmWWAZx99T-Y-Jo8ZL5yCX4t2yIby-7SvQH8uMzfelPxB338Xvc priority: 102 providerName: Directory of Open Access Journals – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rb9MwELfYJBBfEK9BYCAjJvGQojV-Jf5Y9lDL2LQPG-o3y0kcNVJJprTj8Qfxf3LnuoWUCfEpcnO52ufz-Xfx5Y6QPYD1qnSFi3OlZSyYU7DmUh1rIaSVlWXO55k9PVOjS_FxIichQHb-9xE-7Hbgnid8X_gTqS2yBfqFPvlo8juQQ_gaWYDFWay5TMJXeBuPwg5ja8wT1NuAfJ5-_zGuhbZd2-XbU_SIv9U34c7N8Mk_9qPj--ReAJJ0uJz5B-SWax6SO6fhqPwR-TlelR-hbUXHDf1cL7qWjj_FjLYdXhNJh7O2cdisGwqWAbxkP1EU387S0fwqTgfxIejoV1fSRMRfXEfPMQymdPTtxcnhOwq0gCDp0fcQT9vgn52d0AM3g74VvnZa2_2gtimhD9M6r30TwCqwabv5Y3J5fHRxMIpDTYbYAnJaxBYcNKkLLVNuwRoIq7MqrxS4PZlMcwAvskqddtw5DhSD0soSEIJVecrheSv4DtluYGhPCVVFNVAavPPSciEKlUtbgHmxsGNaxVgekfFyxkxYVnNzzjAhnsTDcm5wchOGF7RaGGyy2VBAlAoDECYi71eTboqQ_BxrcMyMd4Kk9NzMUlUisrcmvlrm_LiZ7ANqz5oEE3X7H0B5TVj3JnNY4i3H6sGV0I5ZXWUFSAWGyivFbER2gu6t-QilhUoi8gZV0aCdgZ4WNnwuAbLDjF1miJkidQoALCK7PUqwD0Xv9uugzP8ezKuVohtkgKF3jWuv5waEDCJXPAFOT5aKv2bEuEgBf4N4096S6Mmkf6eppz6JOZdZBtD12X_17jm5y3wZEnz1tUu2F921ewFgcJG_9LbgF2heS0Q priority: 102 providerName: Hindawi Publishing |
Title | Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors |
URI | https://www.airitilibrary.com/Article/Detail/P20160527003-201312-201703020022-201703020022-263-274-124 https://search.emarefa.net/detail/BIM-469461 https://dx.doi.org/10.1155/2013/405295 https://www.ncbi.nlm.nih.gov/pubmed/23476104 https://www.proquest.com/docview/1316056311 https://pubmed.ncbi.nlm.nih.gov/PMC3588175 https://doaj.org/article/8e4179b2152f49e2a9f8cda5ac33f62a |
Volume | 2013 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1rb9Mw0BrjIb4gXoPAqIyYxEMKNPEj8QeEyh5qKZ0mtE79ZjmJQyOVZKQdbD-I_8mdmxZaVXzgSyM354t9vjvf-XFHyB6Y9TKzqfUTqYTPQytB5iLlK86FEbkJrYszOziW3SH_NBKjLbJIxtkQcLrRtcN8UsN68vby-9UHEPj3TuCFAP89YO-427K6Rq7DlBShhA74n7Dhgrs0WmCuh75iImgu6q1VxsDAjINfj1nbbpgCowqtTFcuqr-7umugbJZa_OYY_eefxSYrdf2w5V-z19FdcqcxO2lnzif3yJYt75Nbg2Zj_QH51VskK6FVTnslPStmdUV7n_2QVjU-A0E7k6q0WCxKCnoEfGo3rBTXcml3eu5Hbf8AOPqHzWjA_W-2pid4aCaz9NVp_-A1BViwN-nhZXP6tsSPHffpvp1A21KXaa2qr6gpM2jDuEgKVwTTFtBU9fQhGR4dnu53_SaDg2_Azpr5Btw5oVIlImZAd3Cj4jzJJThJsYgSMHVEHlllmbUMINqZERnYE0YmEYP6hrMdsl1C1x4TKtO8LRX48plhnKcyESYFZWRgfjUyDBOP9OYjphc8pE9CDJ8ncGudaRznIMQH6jg8mrJekAAUcQ0Gj0feLAZdp02odMzYMdHOZRLCYdNzrvHI3hL4fB4hZDPYR-SeJQiG9XZ_VPVX3WgJHVtMCJdgruGcKxsalccpUAW6ynIZGo_sNLy3xMOl4jLwyEtkRY1yAi1NTXO5AmiH8b10B-NKqghkwyO7K5CgTdKV1y8aZv53Z54vGF0jAjyoV9rqYqqByEByyQLA9GjO-EtEC-HySLQiEis0WX1TFmMX8pyJOAZD98l_13xKbocukQkunu2S7Vl9YZ-BOTlLWuBI9fottxjTcmoDfr90R78BfhNn0A |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+In+Vitro+IL-2+or+IL-15+Alone+or+in+Combination+with+Hsp-70-Derived+14-mer+Peptide+%28TKD%29+on+the+Expression+of+NK+Cell+Activatory+and+Inhibitory+Receptors&rft.jtitle=Mediators+of+inflammation&rft.au=Hromadnikova%2C+Ilona&rft.au=Pirkova%2C+Petra&rft.au=Sedlackova%2C+Lucie&rft.date=2013-01-01&rft.pub=Hindawi+Publishing+Corporation&rft.issn=0962-9351&rft.eissn=1466-1861&rft.volume=2013&rft_id=info:doi/10.1155%2F2013%2F405295&rft_id=info%3Apmid%2F23476104&rft.externalDocID=PMC3588175 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon |